Clinical translation of gene expression profiling in lymphomas and leukemias

Seminars in Oncology

Volumn 29, Issue 3, 2002, Pages 258-263

  Rosenwald, Andreas ^a   Staudt, Louis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION REGULATION; HUMAN; LARGE CELL LYMPHOMA; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036272497     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.32901     Document Type: Article

References (22)

1. Lymphoma classification - From controversy to consensus: The R.E.A.L. and WHO classification of lymphoid neoplasms
2. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
3. Genomic views of the immune system
4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
5. Unmutated 1g V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
6. lg V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
7. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
8. Diffuse large cell lymphoma
9. Diffuse large-cell lymphoma
10. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
11. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: Results of a prospective multicenter study by the Kiel Lymphoma Study Group
12. Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma
13. Diffuse large B-cell lymphoma: Is morphologic subdivision useful in clinical management?
14. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma
15. Signatures of the immune response
16. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
17. Biology of chronic lymphocytic leukemia
18. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
19. Constitutive NF-κB activity is required for survival of activated B-like diffuse large B-cell lymphoma cells
20. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB
21. Proteasome inhibition: A new strategy in cancer treatment